semaglutide e tirzepatide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide vs Semaglutide 2026: 22%

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April

Significant weight loss, particularly rapid weight loss, can temporarily disrupt the hypothalamic-pituitary-ovarian (HPO) axis, the hormonal feedback loop that regulates ovulation and menstruation

Key takeaways: across all five SURMOUNT trials, Zepbound consistently produced 14% to 22.5% average weight loss, with the head-to-head data confirming superior efficacy compared to the leading semaglutide-based alternative

We reported the first reversible reaction-based small-molecule fluorescent GSH probe (ThiolQuant Green) that can perform single-point quantification of GSH levels in living cells 15